文献速递中毒与环境急症消化、代谢与肾脏急症

全国急诊实践改进网络中的阿片类药物使用障碍治疗现状

Treatment of Opioid Use Disorder Across a National Emergency Department Practice Improvement Network.
PubMed 文献 · Ann Emerg Med · 2025-10-10
一句话结论在300家急诊科6749次阿片类药物过量或使用障碍就诊中,仅27.8%被处方或发放纳洛酮,未使用MOUD者中仅7.3%被给药或处方MOUD。

本研究基于美国急诊医师学会急诊质量网络物质使用障碍项目,覆盖300家急诊科,随机抽取因阿片类药物过量或阿片类药物使用障碍(OUD)出院的就诊记录进行数据提取。结果显示,在6749次就诊中,纳洛酮被发放或处方于1874次(27.8%);752次(11.1%)就诊报告患者已在服用MOUD,排除这些就诊后,MOUD在急诊给药或出院处方共438次,占潜在合格就诊的7.3%。作者认为这些发现表明急诊OUD治疗存在改进空间。

要点

  • 在300家急诊科6749次阿片类药物过量或OUD就诊中,纳洛酮发放或处方率为27.8%(1874次)。
  • 11.1%(752次)就诊报告患者已在服用MOUD,排除后MOUD给药或出院处方仅占潜在合格就诊的7.3%(438次)。
  • 数据来自美国急诊医师学会急诊质量网络物质使用障碍项目的质量改进计划,数据报告于2023年5月和10月。
  • 作者认为急诊OUD治疗存在改进机会。

适用人群与场景

  • 参与美国急诊医师学会急诊质量网络物质使用障碍项目的急诊科,随机抽取因阿片类药物过量或OUD诊断代码出院的就诊记录。

研究设计与关键结果

  • 研究类型为基于质量改进计划的数据分析,纳入300家急诊科的6749次因阿片类药物过量或OUD就诊。
  • 纳洛酮被发放或处方于1874次就诊(27.8%)。
  • 752次就诊(11.1%)报告患者已在服用MOUD;排除这些就诊后,MOUD在急诊给药或出院处方共438次,占潜在合格就诊的7.3%。

证据类型、等级与局限

  • 证据类型:基于全国实践质量改进计划的数据分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: This study aimed to assess practices surrounding opioid use disorder (OUD), specifically provision of naloxone and medication for OUD (MOUD), in a large sample of emergency departments (EDs) participating in a quality improvement initiative.

METHODS: Data were obtained from EDs participating in the American College of Emergency Physicians' Emergency Quality Network substance use disorder program, a national practice-based quality improvement initiative. ED sites abstracted data elements from a random sample of discharged visits with diagnosis codes for opioid overdose or OUD. Data were reported in May and October 2023 for visits that occurred up to 6 months prior to the reporting period. The percentages of visits for which naloxone was prescribed or dispensed and MOUD was administered or prescribed were determined.

RESULTS: There were 6,749 included visits for overdose or OUD reported from 300 unique EDs. Naloxone was either dispensed or prescribed in 1,874 (27.8%) of visits. There were 752 visits (11.1%) in which it was reported that the patient was already taking MOUD. Excluding those visits, MOUD was either administered in the ED or prescribed at discharge 438 times, representing 7.3% of potentially eligible visits.

CONCLUSION: In this large sample of visits for OUD and overdose, just over a quarter of patients with visits related to opioids were prescribed or dispensed naloxone, and administration or prescription of MOUD to patients not already on it was also low. These findings indicate opportunity for improvement in ED OUD care.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Weiner SG, Venkatesh AK, Sharma PB, et al. Treatment of Opioid Use Disorder Across a National Emergency Department Practice Improvement Network. Ann Emerg Med. 2025. PMID: 41071133. doi:10.1016/j.annemergmed.2025.09.010

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。